Richard S. Levy

2014

In 2014, Richard S. Levy earned a total compensation of $2M as Executive Vice President and Chief Drug Development Officer at Incyte, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$292,180
Option Awards$974,998
Salary$402,977
Stock Awards$324,945
Other$6,818
Total$2,001,918

Levy received $975K in option awards, accounting for 49% of the total pay in 2014.

Levy also received $292.2K in non-equity incentive plan, $403K in salary, $324.9K in stock awards and $6.8K in other compensation.

Rankings

In 2014, Richard S. Levy's compensation ranked 4,513th out of 13,032 executives tracked by ExecPay. In other words, Levy earned more than 65.4% of executives.

ClassificationRankingPercentile
All
4,513
out of 13,032
65th
Division
Services
751
out of 2,086
64th
Major group
Engineering, Accounting, Research, Management, And Related Services
51
out of 191
73rd
Industry group
Research, Development, And Testing Services
13
out of 57
77th
Industry
Commercial Physical and Biological Research
13
out of 47
72nd
Source: SEC filing on April 18, 2016.

Levy's colleagues

We found seven more compensation records of executives who worked with Richard S. Levy at Incyte in 2014.

2014

Hervé Hoppenot

Incyte

Chief Executive Officer

2014

David Gryska

Incyte

Chief Financial Officer

2014

Reid Huber

Incyte

Chief Scientific Officer

2014

James Daly

Incyte

Executive Vice President and Chief Commercial Officer

2014

David Hastings

Incyte

Chief Financial Officer

2014

Wenqing Yao

Incyte

Executive Vice President, Head of Discovery Chemistry

2014

Paul Friedman

Incyte

Chief Executive Officer

You may also like